S
IMNM icon

SignatureFD’s Immunome IMNM Stock Holding History

SignatureFD’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.46K Hold
204
– – ﹤0.01% 2817
2025
Q4 		$4.38K Hold
204
– – ﹤0.01% 2740
2025
Q3 		$2.39K Hold
204
– – ﹤0.01% 2901
2025
Q2 		$1.9K Buy
+204
New +$1.67K ﹤0.01% 2881
2025
Q1 		– Sell
-13
Closed -$138 – 3373
2024
Q4 		$138 Sell
13
-71
-85% -$858 ﹤0.01% 3240
2024
Q3 		$1.23K Buy
+84
New +$1.19K ﹤0.01% 2955

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

SignatureFD's IMNM Position: Q1 2026 in Review

SignatureFD held its Immunome (IMNM) position steady in Q1 2026 at 204 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

SignatureFD first reported a position in IMNM in Q3 2024 and has held it in 6 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • SignatureFD held 204 shares of Immunome worth $4.46K as of Q1 2026.
  • SignatureFD left its Immunome share count unchanged in Q1 2026.
  • Immunome made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2817 holding.
  • SignatureFD first reported a position in Immunome in Q3 2024 and has held it in 6 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.